查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954606

全球DNA連接酶市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析、未來預測（2026-2034）

DNA Ligases Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 請詢問到貨日

價格

DNA連接酶市場成長驅動因素

2025年全球DNA連接酶市場規模為3.7822億美元，預計將從2026年的4.112億美元成長到2034年的8.3046億美元，預測期內年複合成長率（CAGR）為9.18%。北美地區憑藉著強大的生物技術基礎、不斷成長的基因治療研究以及基因編輯工具的快速普及，在2025年佔據了51.21%的市場佔有率，成為市場主導者。

市場概覽

DNA連接酶是催化DNA片段之間磷酸二酯鍵形成的關鍵酶，實現DNA修復、複製和重組。在分子生物學和生物技術產業，這些酵素廣泛應用於DNA克隆、次世代定序（NGS）文庫建構、基因合成和基因組編輯。

基因工程、合成生物學和基因組研究的進步，以及對細胞和基因治療日益成長的需求，推動市場穩步擴張。Thermo Fisher Scientific、Takara Bio Inc. 和 New England Biolabs 等領先公司憑藉其豐富的產品組合和全球分銷網路，佔據了顯著的市場佔有率。

市場動態

市場驅動因素

基因編輯技術的進步

基因編輯技術的快速發展，特別是 CRISPR-Cas9 技術，是推動市場成長的主要動力。 DNA 連接酶在基因工程過程中修復 DNA 鏈方面發揮著非常重要的作用。隨著基於 CRISPR 的療法在癌症治療、遺傳性疾病和自體免疫疾病領域中得到更廣泛的應用，對高效連接酶的需求持續成長。

2024年 9月，KSQ Therapeutics 獲得美國 FDA 批准，啟動其採用 CRISPR 技術的TIL 療法候選藥物的I/II 期臨床試驗。這顯示依賴DNA連接酶的臨床應用日益增多。

市場限制因子

技術挑戰與熟練人員短缺

儘管基因編輯具有很高的成長潛力，但脫靶效應引發了安全性和監管的擔憂。2024年初發表的論文指出，由於非預期的基因組修飾，CRISPR技術有其限制。此外，遞送系統設計、酵素生產規模化以及熟練專業人員短缺等方面的挑戰可能會限制市場擴張。

市場機會

策略聯盟與業務拓展

各公司正積極尋求併購和聯盟，以擴展其基因組技術組合。例如，2021年9月，Fortis Lifesciences收購了Empire Biosciences，增強了其重組蛋白和酵素的生產能力。進軍亞太市場將帶來更多成長機會。

市場挑戰

先進連接酶的高成本限制了其在小型研究機構和發展中國家的應用。此外，基因工程工具嚴格的監管架構可能會延緩產品審批和商業化進程。

市場趨勢

日益關注細胞和基因治療

隨著個人化醫療和基於細胞的基因療法的不斷發展，新的市場趨勢湧現。2025年3月，Neurotec Pharmaceuticals獲得FDA核准用於細胞基因治療，顯示克隆和基因編輯工具（包括DNA連接酶）的重要性日益凸顯。

對酵素技術創新和高效連接酶變體的策略性投資進一步增強了市場前景。

市場區隔分析

依類型

市場依類型分為T4 DNA連接酶、T7 DNA連接酶和其他連接酶。

  • 由於T4 DNA連接酶在克隆和基因工程應用中的高效性和多功能性，在2025年佔據市場主導地位。
  • 受合成生物學和生物製藥研究領域應用日益廣泛推動，預計直至2034年T7 DNA連接酶的年複合成長率將最高。
  • 其他類別（包括耐熱連接酶）在PCR和分子診斷應用領域日益受到關注。

依應用領域劃分

基因組學和基因工程領域在2025年佔據最大佔有率，這得益於基於CRISPR的基因編輯技術和合成生物學的快速發展。

藥物發現和研究領域預計到2034年將以更高的年複合成長率成長，這主要得益於對個人化醫療和合作研究計畫投資的增加。

此外，隨著PCR和NGS技術的日益普及，診斷應用也不斷擴展。

依最終使用者劃分

2025年，製藥和生物技術公司佔據最大市場佔有率，這主要得益於大規模基因治療和疫苗開發計畫的推進。

學術和研究機構構成了一個強大的第二大細分市場，這主要得益於基因組研究經費的增加。

其他細分領域，包括合約研究組織（CRO）和診斷實驗室，由於遺傳疾病的日益普遍以及對分子診斷需求的成長而擴張。

區域展望

北美

到2025年，北美市場規模達到 1.9368億美元，憑藉先進的研究基礎設施和戰略收購，保持其領先地位。美國仍然是主要貢獻者，這得益於基因編輯工具的快速普及。

歐洲

到2025年，歐洲佔據第二大市場佔有率，這得益於其在基因組學領域的強大學術研究和政府投資。德國和英國引領著該地區的研發活動。

亞太地區

預計到2034年，亞太地區將以最高的年複合成長率成長，這主要得益於生物技術製造業的擴張以及諸如Cytiva在中國開展的合作等夥伴關係。

拉丁美洲、中東和非洲

這些地區正經歷溫和成長，這主要得益於基因組學計畫的擴展和對精準醫療投資的增加。沙烏地阿拉伯基因組計畫顯著加速了GCC地區的定序工作。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • DNA修飾技術進展
  • 基因工程技術進展
  • 主要公司新產品發布
  • 關鍵產業趨勢：併購、商業合作等
  • 新冠疫情的影響市場

第5章 全球DNA連接酶市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • T7 DNA
    • T4 DNA
    • 其他
  • 市場分析、洞察與預測：依應用劃分
    • 基因體學與基因工程
    • 藥物發現與研究
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 製藥和生技公司
    • 學術和研究機構
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美DNA連接酶市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲DNA連接酶市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲地區

第8章 亞太地區DNA連接酶市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太地區

第9章 拉丁美洲DNA連接酶市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 中東與非洲DNA連接酶市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • GCC國家
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市場佔有率分析（2025年）
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • New England Biolabs
    • Danaher Corporation
    • Fortis Life Sciences, LLC.
    • Promega Corporation
    • Bio-Rad Laboratories, Inc.
    • BioCat GmbH
    • Takara Bio Inc.
    • Agilent Technologies, Inc.
Product Code: FBI112712

Growth Factors of DNA ligases Market

The global DNA ligases market was valued at USD 378.22 million in 2025 and is projected to grow from USD 411.2 million in 2026 to USD 830.46 million by 2034, registering a CAGR of 9.18% during the forecast period. North America dominated the market with a 51.21% share in 2025, driven by strong biotechnology infrastructure, increasing gene therapy research, and rapid adoption of gene editing tools.

Market Overview

DNA ligases are essential enzymes that catalyze the formation of phosphodiester bonds between DNA fragments, enabling DNA repair, replication, and recombination. In molecular biology and biotechnology industries, these enzymes are widely used for DNA cloning, next-generation sequencing (NGS) library preparation, gene synthesis, and genome editing.

The market is witnessing steady expansion due to advancements in genetic engineering, synthetic biology, genomics research, and increasing demand for cell and gene therapies. Leading players such as Thermo Fisher Scientific Inc., Takara Bio Inc., and New England Biolabs hold significant shares due to their extensive product portfolios and global distribution networks.

Market Dynamics

Market Drivers

Advancements in Gene Editing Technologies

The rapid evolution of gene editing technologies, particularly CRISPR-Cas9, is a major growth driver. DNA ligases play a crucial role in repairing DNA strands during gene manipulation processes. As CRISPR-based therapies gain traction in oncology, genetic disorders, and autoimmune diseases, demand for high-efficiency ligases continues to rise.

In September 2024, KSQ Therapeutics received U.S. FDA clearance to initiate a Phase 1/2 clinical trial for its CRISPR-engineered TIL therapy candidate, highlighting increasing clinical applications that rely on DNA ligases.

Market Restraints

Technical Complications and Skilled Workforce Shortage

Despite strong growth potential, off-target effects in gene editing raise safety and regulatory concerns. Articles published in early 2024 highlight limitations of CRISPR due to unintended genomic modifications. Additionally, challenges in designing delivery systems, scaling enzyme production, and the shortage of skilled professionals may restrain market expansion.

Market Opportunities

Strategic Collaborations and Expansions

Companies are actively pursuing mergers, acquisitions, and partnerships to expand their genomic technology portfolios. For example, in September 2021, Fortis Life Sciences acquired Empirical Bioscience to strengthen its recombinant protein and enzyme manufacturing capabilities. Expansion into Asia Pacific markets presents additional growth opportunities.

Market Challenges

High costs of advanced ligase enzymes limit accessibility for small research institutions and developing countries. Moreover, strict regulatory frameworks surrounding genetic engineering tools can slow product approvals and commercialization.

Market Trends

Rising Focus on Cell & Gene Therapies

The growing shift toward personalized medicine and cell-based gene therapies is shaping new market trends. In March 2025, Neurotech Pharmaceuticals received FDA approval for a cell-based gene therapy, underscoring the increasing importance of cloning and gene editing tools, including DNA ligases.

Strategic investments in enzyme innovation and high-efficiency ligase variants are further strengthening the market outlook.

Segmentation Analysis

By Type

The market is segmented into T4 DNA, T7 DNA, and others.

  • T4 DNA ligase dominated the market in 2025 due to its high efficiency and versatility in cloning and genetic engineering applications.
  • T7 DNA ligase is expected to grow at the highest CAGR through 2034, driven by increasing adoption in synthetic biology and biopharmaceutical research.
  • The others segment, including thermostable ligases, is gaining traction in PCR and molecular diagnostics applications.

By Application

The genomics & genetic engineering segment held the largest share in 2025, supported by rapid advancements in CRISPR-based editing and synthetic biology.

The drug discovery & research segment is anticipated to grow at a higher CAGR through 2034, driven by rising investments in personalized medicine and collaborative research initiatives.

Diagnostics applications are also expanding due to growing adoption of PCR and NGS technologies.

By End-User

Pharmaceutical and biotechnology companies accounted for the largest market share in 2025, driven by extensive gene therapy and vaccine development programs.

Academic & research institutes represent a strong secondary segment, supported by increasing funding in genomics research.

The others segment, including CROs and diagnostic laboratories, is expanding due to rising genetic disease prevalence and demand for molecular diagnostics.

Regional Outlook

North America

North America generated USD 193.68 million in 2025, maintaining leadership due to advanced research infrastructure and strategic acquisitions. The U.S. remains the key contributor, supported by rapid adoption of gene editing tools.

Europe

Europe held the second-largest share in 2025, supported by strong academic research and government investments in genomics. Germany and the U.K. lead regional R&D initiatives.

Asia Pacific

Asia Pacific is projected to grow at the highest CAGR through 2034, driven by expanding biotechnology manufacturing and partnerships such as Cytiva's collaboration in China.

Latin America & Middle East & Africa

These regions are witnessing gradual growth due to expanding genomics programs and rising investment in precision medicine. The Saudi Genome Program has significantly accelerated sequencing initiatives in the GCC region.

Competitive Landscape

The market is semi-consolidated with key players including:

  • Thermo Fisher Scientific Inc.
  • New England Biolabs
  • Takara Bio Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • Danaher Corporation
  • Fortis Life Sciences, LLC.

Strategic investments, manufacturing expansions, and R&D collaborations continue to strengthen competitive positioning.

Conclusion

The global DNA ligases market is poised for substantial growth, expanding from USD 378.22 million in 2025 to USD 830.46 million by 2034, at a CAGR of 9.18%. Rising advancements in gene editing, increasing clinical trials in cell and gene therapies, and expanding genomics research are key growth drivers. While high enzyme costs and regulatory challenges may restrain adoption, strategic collaborations and innovation in high-efficiency ligases are expected to sustain long-term market expansion across global biotechnology and pharmaceutical sectors.

Segmentation By Type

  • T7 DNA
  • T4 DNA
  • Others

By Application

  • Genomics & Genetic Engineering
  • Drug Discovery & Research
  • Others

By End-user

  • Pharmaceutical and Biotechnology Companies
  • Academic & Research Institutes
  • Others

By Region

  • North America (By Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End-user, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in DNA Modification Techniques
  • 4.2. Technological Advancements in Genetic Engineering
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnership, etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global DNA Ligases Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. T7 DNA
    • 5.1.2. T4 DNA
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Genomics & Genetic Engineering
    • 5.2.2. Drug Discovery & Research
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Pharmaceutical and Biotechnology Companies
    • 5.3.2. Academic & Research Institutes
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America DNA Ligases Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. T7 DNA
    • 6.1.2. T4 DNA
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Genomics & Genetic Engineering
    • 6.2.2. Drug Discovery & Research
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Pharmaceutical and Biotechnology Companies
    • 6.3.2. Academic & Research Institutes
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe DNA Ligases Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. T7 DNA
    • 7.1.2. T4 DNA
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Genomics & Genetic Engineering
    • 7.2.2. Drug Discovery & Research
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Pharmaceutical and Biotechnology Companies
    • 7.3.2. Academic & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific DNA Ligases Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. T7 DNA
    • 8.1.2. T4 DNA
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Genomics & Genetic Engineering
    • 8.2.2. Drug Discovery & Research
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Pharmaceutical and Biotechnology Companies
    • 8.3.2. Academic & Research Institutes
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America DNA Ligases Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. T7 DNA
    • 9.1.2. T4 DNA
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Genomics & Genetic Engineering
    • 9.2.2. Drug Discovery & Research
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Pharmaceutical and Biotechnology Companies
    • 9.3.2. Academic & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East and Africa DNA Ligases Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. T7 DNA
    • 10.1.2. T4 DNA
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Genomics & Genetic Engineering
    • 10.2.2. Drug Discovery & Research
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Pharmaceutical and Biotechnology Companies
    • 10.3.2. Academic & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. New England Biolabs
    • 11.2.3. Danaher Corporation
    • 11.2.4. Fortis Life Sciences, LLC.
    • 11.2.5. Promega Corporation
    • 11.2.6. Bio-Rad Laboratories, Inc.
    • 11.2.7. BioCat GmbH
    • 11.2.8. Takara Bio Inc.
    • 11.2.9. Agilent Technologies, Inc.

List of Tables

  • Table 1: Global DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Table 2: Global DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Table 3: Global DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Table 4: Global DNA Ligases Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Table 6: North America DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Table 7: North America DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Table 8: North America DNA Ligases Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: Europe DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Table 10: Europe DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Table 11: Europe DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Table 12: Europe DNA Ligases Market Revenue (USD million) Forecast, by Country/Sub-Region, 2021-2034
  • Table 13: Asia Pacific DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Table 14: Asia Pacific DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Table 15: Asia Pacific DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Table 16: Asia Pacific DNA Ligases Market Revenue (USD million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 17: Latin America DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Table 18: Latin America DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Table 19: Latin America DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Table 20: Latin America DNA Ligases Market Revenue (USD million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 21: Middle East & Africa DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Table 22: Middle East & Africa DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Table 23: Middle East & Africa DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Table 24: Middle East & Africa DNA Ligases Market Revenue (USD million) Forecast, By Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global DNA Ligases Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global DNA Ligases Market Value (USD million), by Region, 2025 & 2034
  • Figure 6: North America DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Figure 7: North America DNA Ligases Market Value Share (%), by Type, 2025
  • Figure 8: North America DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Figure 9: North America DNA Ligases Market Value Share (%), by Application, 2025
  • Figure 10: North America DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Figure 11: North America DNA Ligases Market Value Share (%), by End-user, 2025
  • Figure 12: North America DNA Ligases Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America DNA Ligases Market Value Share (%), By Country, 2025
  • Figure 14: Europe DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Figure 15: Europe DNA Ligases Market Value Share (%), by Type, 2025
  • Figure 16: Europe DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Figure 17: Europe DNA Ligases Market Value Share (%), by Application, 2025
  • Figure 18: Europe DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Figure 19: Europe DNA Ligases Market Value Share (%), by End-user, 2025
  • Figure 20: Europe DNA Ligases Market Value (USD million), By Country/Sub-Region, 2025 & 2034
  • Figure 21: Europe DNA Ligases Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 22: Asia Pacific DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Figure 23: Asia Pacific DNA Ligases Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Figure 25: Asia Pacific DNA Ligases Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific DNA Ligases Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific DNA Ligases Market Value (USD million), By Country/Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific DNA Ligases Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 30: Latin America DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Figure 31: Latin America DNA Ligases Market Value Share (%), by Type, 2025
  • Figure 32: Latin America DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Figure 33: Latin America DNA Ligases Market Value Share (%), by Application, 2025
  • Figure 34: Latin America DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Figure 35: Latin America DNA Ligases Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America DNA Ligases Market Value (USD million), By Country/Sub-Region, 2025 & 2034
  • Figure 37: Latin America DNA Ligases Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 38: Middle East & Africa DNA Ligases Market Value Share (%), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa DNA Ligases Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa DNA Ligases Market Value Share (%), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa DNA Ligases Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa DNA Ligases Market Value Share (%), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa DNA Ligases Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa DNA Ligases Market Value (USD million), By Country/Sub-Region, 2025 & 2034
  • Figure 45: Middle East & Africa DNA Ligases Market Value Share (%), By Country/Sub-Region, 2025